Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.

PloS One
Sundhiya MandaliaNesrina Imami

Abstract

Define and identify long-term non-progressors (LTNP) and HIV controllers (HIC), and estimate time until disease progression. LTNP are HIV-1(+) patients who maintain stable CD4(+) T-cell counts, with no history of opportunistic infection or antiretroviral therapy (ART). HIC are a subset of LTNP who additionally have undetectable viraemia. These individuals may provide insights for prophylactic and therapeutic development. Records of HIV-1(+) individuals attending Chelsea and Westminster Hospital (1988-2010), were analysed. LTNP were defined as: HIV-1(+) for >7 years; ART-naïve; no history of opportunistic infection and normal, stable CD4(+) T-cell counts. MIXED procedure in SAS using random intercept model identified long-term stable CD4(+) T-cell counts. Survival analysis estimated time since diagnosis until disease progression. Subjects exhibiting long-term stable CD4(+) T-cell counts with history below the normal range (<450 cells/µl blood) were compared to LTNP whose CD4(+) T-cell count always remained normal. Within these two groups subjects with HIV-1 RNA load below limit of detection (BLD) were identified. Of 14,227 patients, 1,204 were diagnosed HIV-1(+) over 7 years ago and were ART-naïve. Estimated time until disease p...Continue Reading

References

Mar 1, 1995·Clinical and Diagnostic Laboratory Immunology·S B TugumeE Katongole-Mbidde
Aug 1, 1994·AIDS·P J Easterbrook
Jun 30, 1994·Statistics in Medicine·C M Rutter, R M Elashoff
Oct 1, 1995·Trends in Microbiology·M R Klein, F Miedema
Jan 1, 1996·Annual Review of Microbiology·G Pantaleo, A S Fauci
Dec 1, 1996·Genitourinary Medicine·T T NgW J Morrow
Mar 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·S A MiguelesM Connors
Sep 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olivier LambotteUNKNOWN SEROCO-HEMOCO Study Group
Dec 15, 2007·Biometrics·Keunbaik Lee, Michael J Daniels
Dec 10, 2008·Expert Opinion on Biological Therapy·B M BakerB D Walker
Jul 16, 2010·JAMA : the Journal of the American Medical Association·Stephen A Migueles, Mark Connors
Sep 18, 2010·Nigerian Journal of Medicine : Journal of the National Association of Resident Doctors of Nigeria·S E lsaJ Giyan
Nov 6, 2010·Science·UNKNOWN International HIV Controllers StudyMeng Zhao
Jun 7, 2011·Blood·Asier Sáez-CiriónUNKNOWN ANRS CO18 Cohort

❮ Previous
Next ❯

Citations

Jul 16, 2014·Gastroenterology Research and Practice·Felix Chinweije NwosuKnut Rudi
Aug 21, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Katherine C GrovesAine McKnight
May 24, 2013·Current Opinion in HIV and AIDS·Caroline A Sabin, Jens D Lundgren
Oct 2, 2015·The Lancet. HIV·Jannie J van der HelmUNKNOWN CASCADE Collaboration in EuroCoord
Jun 7, 2014·Frontiers in Immunology·Archana Gopal KulkarniMadhuri Rajeev Thakar
Feb 4, 2014·PloS One·Ashley D OlsonUNKNOWN CASCADE Collaboration in EuroCoord
Nov 22, 2018·Frontiers in Immunology·Gilberto FilaciAntonio Di Biagio
Dec 14, 2018·HIV Clinical Trials·Mariya V SivaySusan H Eshleman

❮ Previous
Next ❯

Software Mentioned

SAS
Statistical Analysis
GISHEAL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.